Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Engelhardt

Showing results (251-260 of 266) with videos related to

Pageof 27
Sort By:
Leukemia|January 12, 2017
Olaptesed pegol, an anti-CXCL12/SDF-1 Spiegelmer, alone and with bortezomib-dexamethasone in relapsed/refractory multiple myeloma: a Phase IIa StudyH Ludwig, K Weisel, M T Petrucci, et al.
Journal of Hematology & Oncology|January 18, 2018
Diagnosis, treatment, and response assessment in solitary plasmacytoma: updated recommendations from a European Expert PanelJ Caers, B Paiva, E Zamagni, et al.
Leukemia|April 26, 2017
Lenalidomide, adriamycin, dexamethasone for induction followed by stem-cell transplant in newly diagnosed myelomaS Knop, C Langer, M Engelhardt, et al.
The Science of the Total Environment|February 26, 2019
Critical mercury concentration in tropical soils: Impact on plants and soil biological attributesF R D Lima, G C Martins, A O Silva, et al.
Leukemia|March 16, 2017
Response-adapted consolidation with bortezomib after ASCT improves progression-free survival in newly diagnosed multiple myelomaH Einsele, S Knop, M Vogel, et al.
Journal of Internal Medicine|February 7, 2019
Prevention, monitoring and treatment of cardiovascular adverse events in myeloma patients receiving carfilzomib A consensus paper by the European Myeloma Network and the Italian Society of Arterial HypertensionS Bringhen, A Milan, M D'Agostino, et al.
Health Physics|February 27, 2013
The Gulf War depleted uranium cohort at 20 years: bioassay results and novel approaches to fragment surveillanceMelissa A McDiarmid, Joanna M Gaitens, Stella Hines, et al.
Molecular Genetics and Metabolism Reports|November 24, 2022
Malate dehydrogenase 2 deficiency is an emerging cause of pediatric epileptic encephalopathy with a recognizable biochemical signatureJessica R C Priestley, Lisa M Pace, Kuntal Sen, et al.
Journal of Inherited Metabolic Disease|February 14, 2021
Expanding the phenotype, genotype and biochemical knowledge of ALG3-CDGHind Alsharhan, Bobby G Ng, Earnest James Paul Daniel, et al.
Science Advances|April 15, 2026
Targeted long-read RNA sequencing for rare disease diagnosis and variant interpretationRobert Wang, Feng Wang, Nicole DeBruyne, et al.
Pageof 27

Showing results (251-260 of 266) with videos related to

Sort By:
Pageof 27
Leukemia|January 12, 2017
Olaptesed pegol, an anti-CXCL12/SDF-1 Spiegelmer, alone and with bortezomib-dexamethasone in relapsed/refractory multiple myeloma: a Phase IIa StudyH Ludwig, K Weisel, M T Petrucci, et al.
Journal of Hematology & Oncology|January 18, 2018
Diagnosis, treatment, and response assessment in solitary plasmacytoma: updated recommendations from a European Expert PanelJ Caers, B Paiva, E Zamagni, et al.
Leukemia|April 26, 2017
Lenalidomide, adriamycin, dexamethasone for induction followed by stem-cell transplant in newly diagnosed myelomaS Knop, C Langer, M Engelhardt, et al.
The Science of the Total Environment|February 26, 2019
Critical mercury concentration in tropical soils: Impact on plants and soil biological attributesF R D Lima, G C Martins, A O Silva, et al.
Leukemia|March 16, 2017
Response-adapted consolidation with bortezomib after ASCT improves progression-free survival in newly diagnosed multiple myelomaH Einsele, S Knop, M Vogel, et al.
Journal of Internal Medicine|February 7, 2019
Prevention, monitoring and treatment of cardiovascular adverse events in myeloma patients receiving carfilzomib A consensus paper by the European Myeloma Network and the Italian Society of Arterial HypertensionS Bringhen, A Milan, M D'Agostino, et al.
Health Physics|February 27, 2013
The Gulf War depleted uranium cohort at 20 years: bioassay results and novel approaches to fragment surveillanceMelissa A McDiarmid, Joanna M Gaitens, Stella Hines, et al.
Molecular Genetics and Metabolism Reports|November 24, 2022
Malate dehydrogenase 2 deficiency is an emerging cause of pediatric epileptic encephalopathy with a recognizable biochemical signatureJessica R C Priestley, Lisa M Pace, Kuntal Sen, et al.
Journal of Inherited Metabolic Disease|February 14, 2021
Expanding the phenotype, genotype and biochemical knowledge of ALG3-CDGHind Alsharhan, Bobby G Ng, Earnest James Paul Daniel, et al.
Science Advances|April 15, 2026
Targeted long-read RNA sequencing for rare disease diagnosis and variant interpretationRobert Wang, Feng Wang, Nicole DeBruyne, et al.
Pageof 27